Review
Open access
Aug 2026
Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis.
3-month DAPT followed by monotherapy significantly reduces bleeding without increasing ischemic events and crosses the futility boundary for MACCE and the benefit boundary for CRB, indicating conclusive evidence for bleeding reduction and futility for ischemic benefit.
C. Chinnatambi, Abdul Rahaman Ottun, Louise Sakowski et al.
· Cardiovascular Revasculariza... · 0 citations